Cited by 285Genital Health and DiseaseCervical Cancer and HPV ResearchReproductive tract infections research

Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa.

Open access
Auvert, Bertran, Sobngwi-Tambekou, Joelle, Cutler, Ewalde, Nieuwoudt, Marthi, Lissouba, Pascale, Puren, Adrian, Taljaard, Dirk·2009·Journal of Infectious Diseases

Abstract

BACKGROUND: A causal association links high-risk human papillomavirus (HR-HPV) and cervical cancer, which is a major public health problem. The objective of the present study was to investigate the association between male circumcision (MC) and the prevalence of HR-HPV among young men. METHODS: We used data from a MC trial conducted in Orange Farm, South Africa, among men aged 18-24 years. Urethral swab samples were collected during a period of 262 consecutive days from participants in the intervention (circumcised) and control (uncircumcised) groups who were reporting for a scheduled follow-up visit. Swab samples were analyzed using polymerase chain reaction. HR-HPV prevalence rate ratios (PRRs) were assessed using univariate and multivariate log Poisson regression. RESULTS: In an intention-to-treat analysis, the prevalences of HR-HPV among the intervention and control groups were 14.8% (94/637) and 22.3% (140/627), respectively, with a PRR of 0.66 (0.51-0.86) (P = .002). Controlling for propensity score and confounders (ethnic group, age, education, sexual behavior [including condom use], marital status, and human immunodeficiency virus status) had no effect on the results. CONCLUSIONS: This is the first randomized controlled trial to show a reduction in the prevalence of urethral HR-HPV infection after MC. This finding explains why women with circumcised partners are at a lower risk of cervical cancer than other women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/595566

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Male circumcision is highly protective against urinary tract infections, inflammatory conditions of the penis, sexually transmitted infections, and urogenital cancers.

    “Male circumcision is a highly effective medical procedure that is protective against various medical conditions including urinary tract infections, inflammatory conditions of the penis, sexually transmitted infections—such as those caused by human papillomaviruses, herpes simplex virus type 2, and human immunodeficiency virus (HIV)—and urogenital cancers.1-7”

    From Rapid Training and Implementation of the Pollock Technique, a Safe, Effective Newborn Circumcision Procedure, in a Low-Resource Setting (2015) · cites this paper as [2]

    The Results and Conclusions (p. 1) report lower urethral high-risk HPV prevalence among circumcised young men, and the introduction (p. 1) describes a partial protective effect against HIV. This paper does not establish protection against urinary tract infections, penile inflammatory conditions, HSV-2, or urogenital cancers; its cancer discussion concerns the implications of reduced HPV infection. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • In those trials, circumcision also was protective against other STIs, including high-risk genital HPV infection and genital herpes.

    “In those trials, circumcision also was protective against other STIs, including high-risk genital HPV infection and genital herpes (66–68).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [67]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Auvert, B., Sobngwi-Tambekou, J., Cutler, E., Nieuwoudt, M., Lissouba, P., Puren, A., & Taljaard, D.
Affiliations
  • Inserm (FR)
  • National Institute for Communicable Diseases (ZA)
Corresponding author
Auvert, Bertran
Venue
Journal of Infectious Diseases
Published
2009-01-01
Volume
199
Issue
1
Pages
14-19
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2132386620
Cited by
285
References
24
Citations by year
2025: 4 · 2024: 5 · 2023: 3 · 2022: 9 · 2021: 6 · 2020: 5 · 2019: 15 · 2018: 7 · 2017: 21 · 2016: 15 · 2015: 17 · 2014: 28 · 2013: 28 · 2012: 34
FWCI
30.92
Type
journal article
Language
en
Open access
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Surgery › Genital Health and Disease
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords
male circumcision, high-risk HPV, HPV prevalence, young men, cervical cancer prevention, sexually transmitted infections, condom use, HIV status
MeSH terms
Adolescent, Circumcision, Male, Gonorrhea, Humans, Male, Neisseria gonorrhoeae, Risk Factors, Sexual Behavior, South Africa, Urethra, HIV Infections, Prevalence, Risk Assessment, Papillomavirus Infections, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review